Orexo AB (publ) (ORXOY) Q4 2025 Earnings Call Transcript

February 05, 2026 02:54:21 pm

Source: SeekingAlpha

2026-02-05 14:54:21 ET

Orexo AB (publ) (ORXOY) Q4 2025 Earnings Call February 5, 2026 8:00 AM EST

Company Participants

Nikolaj Sørensen - President & CEO
Frederik Jarrsten - Executive VP & CFO

Conference Call Participants

Klas Palin - DNB Carnegie Commissioned research
Samir Devani - Rx Securities Limited, Research Division
...

For further details see:

Orexo AB ADR

237.22% G/L:

$2.60 Last:

100 Volume:

$2.60 Open:

September 05, 2025 08:28:00 am

June 02, 2025 09:09:00 am

April 10, 2025 02:21:00 am

January 10, 2025 08:18:00 am

Market Cap $89,304,181

Float 28,711,294

Insiders Ownership N/A

Institutions

Short Percent N/A

Industry Pharmaceuticals

Sector Healthcare

Country SE

City Uppsala